Accueil  >>  Master  >>  Biologie moléculaire et cellulaire  >>  Leading international vaccinology education (ERASMUS+)  >>  Novel technologies, vaccine administration
  • Domaine : Masters du domaine SCIENCES, TECHNOLOGIES, SANTE
  • Diplôme : Master
  • Mention : Biologie moléculaire et cellulaire
  • Parcours : Leading international vaccinology education (ERASMUS+)
  • Unité d'enseignement : Novel technologies, vaccine administration
Nombre de crédits de l'UE : 3
Code APOGEE : BIO1310M
UE Obligatoire pour ce parcours
UE valable pour le semestre 2 de ce parcours
    Responsabilité de l'UE :
DELPRAT CHRISTINE
 christine.delpratuniv-lyon1.fr
04.72.68.19.54
    Type d'enseignement
Nb heures *
Cours Magistraux (CM)
20 h
Travaux Dirigés (TD)
10 h
Travaux Pratiques (TP)
0 h
Total du volume horaire
30 h
* Ces horaires sont donnés à titre indicatif.
    Programme - Contenu de l'UE :
University of Antwerp
Contact : Delputte Peter, Professor
email : peter.delputte@uantwerpen.be
Keywords : novel technology, adjuvant, immunology, vaccine development, mode of action, toll-like receptor, route of administration, clinical research, vaccine safety

Aims of “Vaccine administration routes & adjuvants”

This course will be designed in close collaboration with our industrial partners

-          Adjuvant definition Adjuvant families

-          Role of adjuvants: Why do we need adjuvants?

-          Matching the right one: Antigens may need help - why and when?

-          General adjuvant mode of action (MoA): immunological interpretation, relationship between innate and adaptive immunity

-          Pre-clinical and clinical experience using novel adjuvants in vaccine formulations, impact on immune response

-          Clinical tolerability, safety considerations and current safety profile of adjuvanted vaccines

-          Learning & challenges in developing, manufacturing and licensing AS-containing vaccines

-          Considerations for use of adjuvanted vaccines in special populations

-          Novel technologies, including routes of administrations

-          Advances in Immunology and Vaccine Discovery: Considerations for future applications-           

Tutorials: will involve the reading relevant articles covering various topics of this course. Series of didactic presentations and practical exercises through group work. 

Speakers:
Marcelle Van Mechelen, Alberta Di Pasquale, Gérald Voss, Arnaud Didierlaurent, Fernanda Tavares Da Silva, Ozzie Berger, Jean Gilliard 

Learning outcomes:
Strengthen capacity in vaccinology with comprehensive overview of  the field, discuss recent scientific advances contributing to the progress of vaccine development, specifically related to adjuvants, novel technologies and routes of administrations.


Updated on April 9, 2019

    Modalités de contrôle des connaissances et Compétences 2018-2019 :
TypeLibelléNatureCoef. 
CTContrôle TerminalCT : Novel techn. vaccine adminstrationEcrit session 1 / Ecrit session 23
    Liste des autres Parcours / Spécialité / Filière / Option utilisant cette UE :
Date de la dernière mise-à-jour : 09/04/2019
SELECT * FROM parcours INNER JOIN ue_parcours ON PAR_ID_FK=PAR_ID INNER JOIN mention ON MEN_ID = PAR_MENTION_FK WHERE PAR_ACTIVATE = 0 AND UE_ID_FK='16692' ORDER BY UE_ID_FK ASC, PAR_ID_FK ASC